Virus Molecular Interactions: Therapeutic Targets

Topics: Biochemistry, Medicinal Chemistry, Keywords: see below

Date: /17/18/19/ September 2007, Oxford, United Kingdom, Europe

Web Site, Contact: see Web Site

  

Official Information:

Introduction

In a little over one decade, antiviral chemotherapy has progressed from being an obscure and speculative branch of pharmaceutical chemistry to being a topic of regular newsworthy interest. This change has resulted from three important developments:

(i) the emergence of new viral infections of global impact and potential economic importance, such as HIV, SARS, West Nile, Marburg virus and Influenza H1N2.
(ii) structural and molecular virology has made spectacular advances in our understanding of the basic interactions, between the virus and its host, that underlie replication and pathogenesis.
(iii) developments in pharmaceutical chemistry, including high-throughput screening, structure-based drug design, combinatorial chemistry and rational drug design have made it possible to discover, validate and develop potential therapeutic leads with vastly greater speed and power than heretofore.

This joint RSC / Biochemical Society conference will be a timely opportunity to bring together experts in these three areas in order to promote further developments in fundamental and applied research in this field.

Themes

The conference will comprise of four half-day sessions in the following areas: